Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Former Lilly Scientists Fighting Wire Fraud Charges Battle Over Documents
WSJ Online
Thursday, July 31, 2014 - 10:00am
tags:
Eli Lilly, wire fraud, fraud, China
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
BioSpace
Thursday, July 31, 2014 - 9:42am
tags:
Dendreon, JNJ, Pharma CEOs, W. Thomas Amick
To Tweet or Not to Tweet? Or Even Retweet? FDA, Tweeting and Twitter
Eye on FDA
Thursday, July 31, 2014 - 9:34am
tags:
social media, FDA, twitter
Valeant Pharmaceuticals posts 12-fold rise in net profit
Yahoo/Reuters
Thursday, July 31, 2014 - 9:32am
tags:
earnings, Valeant Pharmaceuticals
Flu season should return Sanofi to double-digit vaccines growth, CEO says
Fierce Vaccines
Thursday, July 31, 2014 - 9:31am
tags:
Sanofi, Pharma CEOs, Chris Viehbacher, vaccines, Flu, flu vaccines
AstraZeneca steps up push into cancer immunotherapy
Yahoo/Reuters
Thursday, July 31, 2014 - 9:16am
tags:
cancer immunotherapy, AstraZeneca, MEDI4736
Endo raises forecast, reports better-than-expected profit
Yahoo/Reuters
Thursday, July 31, 2014 - 9:15am
tags:
earnings, Endo Health Solutions
Teva Quarterly Profit Rises on New Version of MS Drug
Bloomberg
Thursday, July 31, 2014 - 9:14am
tags:
Teva Pharmaceutical, earnings
Meda to Buy Rottapharm for $3.1 Billion to Add OTC Brands
Bloomberg
Thursday, July 31, 2014 - 9:13am
tags:
Meda, Rottapharm, M&A
Sanofi Raises Profit Forecast on Diabetes, Orphan Drugs
Bloomberg
Thursday, July 31, 2014 - 9:12am
tags:
earnings, Sanofi
AstraZeneca smashes forecasts in Q2 after seeing off Pfizer
Yahoo/Reuters
Thursday, July 31, 2014 - 9:10am
tags:
earnings, AstraZeneca
Gilead bags a portfolio of HIV-neutralizing antibodies
Fierce Biotech
Wednesday, July 30, 2014 - 6:37pm
tags:
Gilead Sciences, antibodies, HIV
J&J seeks return of device seen as possibly raising cancer risk
Yahoo/Reuters
Wednesday, July 30, 2014 - 6:23pm
tags:
JNJ, Ethicon, devices, recalls, laparoscopic power morcellators
Valeant To Report Strong Second-Quarter Earnings And Revenues
Bidness Etc
Wednesday, July 30, 2014 - 6:12pm
tags:
Valeant Pharmaceuticals, earnings
Teva says shareholders favor management as shakeup fizzles
Yahoo/Reuters
Wednesday, July 30, 2014 - 6:11pm
tags:
Teva Pharmaceutical
U.S. FDA panel reviews Baxter immune therapy's long-term safety
Yahoo/Reuters
Wednesday, July 30, 2014 - 6:10pm
tags:
FDA, Baxter International, HyQvia
Novartis Malaria Pill Shows Promise as Best Drugs Fail
Bloomberg
Wednesday, July 30, 2014 - 6:07pm
tags:
malaria, Novartis, KAE609
Why There's Far More To Pfizer Than Viagra
Investopedia
Wednesday, July 30, 2014 - 6:06pm
tags:
Pfizer, GSK, Eli Lilly
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
TheStreet.com
Wednesday, July 30, 2014 - 11:16am
tags:
Amgen, layoffs
Nobel Biocare Confirms Talks About Sale of Implant Maker
Bloomberg
Wednesday, July 30, 2014 - 9:32am
tags:
Nobel Biocare, dental implants, M&A, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.